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Abstract: Coronary artery graft surgery (CABG) using a cardiopulmonary bypass (CPB) 
pump to allow for stopping the heart, commonly designated as “on pump CABG” or 
ONCAB, requires complete anticoagulation and is associated with significant 
postoperative anemia. In addition, a reduction in postoperative platelet counts is relatively 
common in large part due to heightened activation of hemostatic pathways and platelet 
consumption secondary to blood passing through the CPB circuit. It has been 
demonstrated that both anemia and nadir platelet counts after ONCAB are associated 
with the incidence and severity of postoperative acute kidney injury (AKI). Over the past 
several years, techniques have been refined for performing CABG without CPB, 
commonly designated as “off pump CABG” or simply OPCAB.  This approach removes 
the need for anticoagulation thus potentially reducing postoperative bleeding and anemia, 
and negates the effect of CPB on platelet consumption. Whether OPCAB surgery 
mitigates the severity of postoperative anemia and thrombocytopenia relative to ONCAB, 
however, remains unclear. Furthermore, it remains unknown if the association between 
nadir platelet counts and AKI evident in ONCAB patients is present following OPCAB. 
The present study was designed to test the hypotheses that: a) nadir platelet counts and 
hemoglobin values, as well as bleeding and transfusion requirements differ between 
ONCAB and OPCAB surgeries; b) the postoperative recovery of platelet counts and 
hemoglobin values is more protracted in ONCAB vs. OPCAB; and c) that hemostatic 
derangements are more closely associated with postoperative AKI in ONCAB as 
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compared to OPCAB surgeries.      
Methods: With IRB approval, a retrospective study from a single institution was 
conducted involving 634 adult patients undergoing elective OPCAB (n=255) or ONCAB 
(n=379).  Data were captured for demographics, medical history, surgical characteristics, 
postoperative blood loss (defined as chest tube output in the first 48 hours), hemoglobin 
levels and platelet counts, and blood product transfusions. Between groups, daily median, 
postoperative nadir, and discharge values for hemoglobin and platelets were compared 
with nadir counts defined as the median lowest in-hospital value measured over the first 5 
postoperative days and at discharge. In addition, the incidence of frank 
thrombocytopenia, defined as platelet values of < 74 x 109/dL, was compared along with 
the administration of packed red blood cells (RBC), fresh frozen plasma (FFP) and 
platelet suspensions. AKI was defined according to KDIGO criteria, whereby 
postoperative serum creatinine rise >50% or 0.3 mg/dL was indicative of injury. The 
incidence of AKI was then determined for the OPCAB and ONCAB groups, both as a 
whole and when subdivided into the segment of each group that was thrombocytopenic.  
Results: The ONCAB and OPCAB cohorts were similar in regard to age  (67 + 10  vs 67 
+ 10), and male/female distribution (80/20 vs 72/28). For both groups, the median nadir 
platelet values were observed on the second postoperative day and were not different 
(145K vs 142K, p =0.44). Similarly, the incidence of thrombocytopenia was the same 
following both OPCAB and ONCAB (5.88% vs. 5.54%) surgeries.  Median nadir 
postoperative hemoglobin concentration in OPCAB patients was 10.10 mg/dl and 
occurred on postoperative day 2. In ONCAB patients, the median nadir postoperative 
hemoglobin concentration was not different (9.90 mg/dl, p = 0.95) but occurred on 
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postoperative 4.  There was no difference in postoperative bleeding measured by chest 
tube output between ONCAB vs. OPCAB (892 + 421 mL vs. 850 + 441 mL, p = 0.24).  
The incidence of red blood cell (RBC) transfusion was comparable between groups. In 
contrast, both rates of FFP (ONCAB 20% vs. OPCAB 8%; p<0.001) as well as platelet 
transfusion (ONCAB 35% vs. OPCAB 10%; p<0.001) were different. Overall the pattern 
of postoperative platelet recovery was comparable, with both cohorts recovering beyond 
baseline values by postoperative day 5. The overall incidence of postoperative AKI was 
comparable between ONCAB vs. OPCAB [33.3% (n=126) and 34.5% (n = 88)].  Patients 
(combined ONCAB and OPCAB) who developed severe thrombocytopenia (n=36) had a 
higher rate of AKI as compared to those with normal platelet counts (55.6% vs. 32.4%; 
p=0.004). Further, intragroup analysis (ONCAB only) demonstrated a higher incidence of 
AKI in those with severe postoperative thrombocytopenia as compared to patients with 
“normal” platelet counts [62% (n=13) vs. 32% (n = 113); p =<0.004]. However, the same 
analysis of OPCAB patients showed no difference in the incidence of AKI [47% (n =7) 
vs. 34% (n=81); p = 0.31] for severe thrombocytopenia vs. normal platelet counts. 
Conclusion: Our findings demonstrate that contrary to the study hypotheses, ONCAB 
and OPCAB surgeries are actually similar in regard to postoperative thrombocytopenia, 
anemia, bleeding, red blood cell transfusion rates, and recovery patterns for hemoglobin 
and platelets. Despite these similarities, there were higher rates of FFP and platelet 
transfusions in the ONCAB group.   Overall, the incidence of AKI was the same when 
comparing the entirety of both groups.  However, in the subgroup of patients with 
postoperative thrombocytopenia, patients who underwent ONCAB had a markedly higher 
rate of AKI.  
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Introduction 
 
In the United States, nearly 200,000 patients undergo coronary artery bypass graft 
(CABG) procedures yearly for medically refractory coronary artery diesease.1 Such 
coronary revascularization has traditionally been performed with use of an extracorporeal 
apparatus named cardiopulmonary bypass (CPB)- allowing the heart to be arrested 
pharmacologically with cardioplegia.  This approach has been further characterized as 
on-pump CABG or “ONCAB”; whereas, CABG performed without CPB (off-pump) is 
termed “OPCAB”.  
Most complex cardiac surgical procedures require use of CPB.  Employing this 
approach offers many advantages such as providing a bloodless field via diversion of 
blood to the CPB circuit, i.e., bypassing the heart. On the other hand, it also introduces 
several physiologic, metabolic, and hematologic derangements that influence morbidity 
and mortality.2,3  For example, hemodilution, consumption of coagulation factors and 
fibrinogen, and platelet abnormalities can potentiate bleeding and anemia that, in turn, 
would necessitate transfusion of blood products.4,5  Contact activation between blood and 
the extracorporeal material also triggers significant cellular and inflammatory responses 
and ischemia-reperfusion injuries, which have systemic effects including acute end-organ 
failure such as acute kidney injury (AKI).6  Moreover, cardiac surgery including OPCAB 
can generate microemboli arising from intracardiac sources and from aortic atheromatous 
placques.7 Microaggregates formed from activated leukocytes and activated platelets may 
be pivotal in the pathogenesis of postoperative stroke, acute respiratory failure, and AKI.8  
The coagulation factors, platelets, fibrinogen, and leukocytes are not only exposed to the 
non-biologic surface of the machine, but must endure the sheering forces of the CBP 
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machine.7,9 This may lead to release of cytokines that promote further microthrombi, 
exacerbating thrombocytopenia.10  
In order to mitigate CPB associated complications, cardiac surgeons may opt to 
perform OPCAB.  Development of cardiac stabilizers has made it possible to conduct 
CABG surgery on a beating heart and thereby avoid cardiac arrest and CPB. Ascione et 
al. found that OPCAB is associated with a significant reduction in inflammatory response 
and postoperative infection when compared with conventional revascularization with 
ONCAB.11  OPCAB, however, is technically more challenging.  Nevertheless, in a 
retrospective review of the STS National Adult Cardiac Database, Polomsky et al. 
analyzed 876,081 patients who underwent CABG between January 1, 2005 and 
December 31, 2010.12  They concluded that OPCAB was associated with reduced risk of 
death, stroke, acute renal failure, mortality or morbidity, and prolonged length of stay 
compared with ONCAB.12 In contrast, Schopka et al. conducted a matched-pair analysis 
of 1428 patients undergoing CABG.13 The patients were further stratified according to 
their preoperative renal function, as ascertained from glomerular filtration rate (GFR) and 
to risk of postoperative AKI.  They concluded that use of CPB or its duration did not 
increase risk or severity of postoperative AKI.13 Thus, there remains on going 
controversies and inconclusive information regarding incremental benefits of OPCAB 
over ONCAB.  It is also uncertain whether OPCAB offers advantage over ONCAB with 
regards to hemostatic derangements (thrombocytopenia, anemia, bleeding, and 
transfusion requirements).  At our Institution, OPCAB surgery is performed by one 
surgeon, whereas, several surgeons perform ONCAB.  This unique environment, allowed 
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us to design a retrospective study investigating aforementioned hematologic changes in 
ONCAB vs. OPCAB.  
  
Primary Aim: To compare hemostatic derangements (thrombocytopenia, anemia, 
bleeding, transfusions) between ONCAB vs. OPCAB surgeries  
Secondary Aim: (1) To compare and characterize postoperative patterns of recovery of 
both thrombocytopenia and anemia in ONCAB vs. OPCAB surgeries (2) and to 
investigate whether hemostatic derangements in ONCAB and in OPCAB surgeries relate 
to postoperative AKI. 
• We hypothesize that hemostatic responses (nadir platelet counts, nadir hemoglobin 
values, bleeding, and transfusion requirements) will differ in ONCAB vs. OPCAB 
surgeries.   
• We also hypothesize that the postoperative pattern of recovery of nadir platelet 
counts and of nadir hemoglobin values will be significantly more protracted in 
ONCAB vs. OPCAB.   
• Lastly, we hypothesize that hemostatic derangements will be significantly 
associated with postoperative AKI in ONCAB as compared to OPCAB surgeries.      
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Methods 
Approval by the Institutional Review Board for Clinical Investigations, Yale University 
School of Medicine, New Haven, CT was obtained. 
 
Data Collection and Measurements  
The following data were retrospectively collected on 634 adult patients who 
underwent non-emergent ONCAB or OPCAB surgeries at Yale New Haven Hospital, 
New Haven, CT: age, gender, race and ethnicity, height, weight, blood pressure, history 
of COPD, CVA, recent MI, CPB time, aortic cross clamp time, surgical course, 
laboratory values (platelets, hemoglobin, chemistry profile), perioperative medications, 
and clinical outcomes.  Hemoglobin values, platelet counts, and serum creatinine data 
were collected from time of patient admission to hospital discharge. Three independent 
investigators (STK*1, MMM*, AN*) verified the data quality by performing regular 
crosschecks for completeness and consistency between the data set assembled and the 
information available from the electronic medical records.  STK created a java program in 
order to format data collection into an excel file.  
  
Definitions 
The primary aim involved comparison of “hemostatic derangements” that 
included: baseline platelets, daily nadir platelet counts; baseline hemoglobin, nadir 
hemoglobin values, postoperative bleeding (postoperative 48 hour chest tube outputs), 
transfusions (red blood cells, fresh frozen plasma, cryoprecipitate, cell saved blood, and 
                                                
1	MMM	–	Miriam	Monteiro-Mascarenhas	AN	–Adambeke	Nwozuzu		
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platelets). Baseline laboratory values indicate preoperative measurements closest to the 
date of surgery.  Subsequent measurements were characterized as day of surgery (DOS), 
postoperative day (POD) 1, 2, 3, etc., and day of discharge from the hospital (Discharge).  
Nadir platelet counts was defined as the median of the lowest in-hospital values measured 
for the first 7 postoperative days and at discharge.  Also nadir hemoglobin value was 
defined as the median of the lowest in-hospital values measure for the first 7 days 
postoperatively and at discharge. Likewise, we also recorded perioperative creatinine 
values and defined baseline creatinine as the preoperative closest to the date of surgery.  
An algorithm was constructed to ensure consistency for recording baseline creatinine 
values.    
Acute kidney injury was defined according with the Kidney Disease Improving 
Outcomes (KIDGO) guidelines. Briefly, KIDGO separates AKI into 3 stages. Stage 1a. 
Serum creatinine increase of (≥0.3 mg/dl) within a 48 hr. interval; 1b- an increase of 
creatinine levels of 1.5-1.9 times baseline recordings; stage 2 AKI as a serum creatinine 
increase of  >2.0–3.0-times baseline recordings; stage 3a AKI serum creatinine increase 
of >3.0-times baseline recordings; and stage 3b as serum creatinine of (≥4.0 mg/dl) with 
an acute increase of at least (0.5 mg/dl). 
  Lastly, severe thrombocytopenia was defined as platelet values < 74 x 109/dL 
based on the lowest tertile median value from our study cohorts.  
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Statistics 
The Wilcoxon rank sum test was used for statistical analysis of hemoglobin and platelet 
values.  Hemoglobin, platelets, creatinine percent change was calculated by dividing the 
patients baseline lab value into the patient’s daily lab value minus baseline lab value: 
Percent Change =         Daily lab value – Baseline lab value 
        Baseline lab value 
 
Absolute change was calculated by subtracting baseline lab value, from Daily lab value, 
          Absolute change =       Daily lab value – Baseline lab value 
The means for these values for each group + 95% confidence upper and lower limits were 
plotted against, postoperative day.  T-test was used for the following comparisons 
between ONCAB and OPCAB: demographics, clinical and surgical characteristics, 
hemostatic responses (transfusion, bleeding), intraoperative, and postoperative 
pharmacological therapy categories.   Chi-square test was used to calculate rates of AKI. 
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Results 
In total, 634 patients were included in our retrospective study.  The ONCAB 
cohort consisted of 369 patients, while the OPCAB cohort consisted of 255 patients.  
Demographic, medical, surgical characteristics are presented on table 1.   
 
Perioperative Platelets Trajectory and Recovery 
The median baseline, nadir, and discharge values for platelet counts were similar 
in ONCAB vs. OPCAB and are shown in table 2.  The median nadir platelet values were 
observed on POD2 for both groups (145K vs. 142K, p =0.44).  The pattern of daily 
decline and recovery of platelet counts was also similar in ONCAB vs. OPCAB; albeit, 
non-clinically significant differences were observed between the two cohorts.  For 
example, on POD3 and POD4, the median platelet counts were (156K vs. 163K, p = 
<0.04 and 191K vs. 202K, p=0.035) for ONCAB vs. OPCAB, respectively.  Figure 1 
depicts postoperative platelet counts according to percent change and absolute change 
from baseline platelet values. Overall, the incidence of thrombocytopenia was similar in 
OPCAB vs. ONCAB (5.88% vs. 5.54%) surgeries.  
Perioperative Anemia and Recovery 
Median baseline, nadir, and discharge hemoglobin values are presented in table 3.  
Overall, nadir postoperative hemoglobin concentration was 10.10 mg/dl and occurred on 
POD2 in OPCAB patients; whereas, in ONCAB patients, the minimum median 
postoperative hemoglobin concentration was 9.90 mg/dl- occurring on POD4. Using the 
Wilcoxon rank sum test, there was a significant difference in median hemoglobin values 
on POD4, POD5, and on day of discharge between groups (table 3).    Figure 2a and 2b 
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summarize perioperative patterns of hemoglobin- depicting its percent and absolute 
changes from baseline. Such patterns of hemoglobin decline was similar in ONCAB vs. 
OPCAB. Further, our results show markedly protracted recovery of in-hospital anemia 
for both groups. 
Transfusion of Blood Products 
Table 4 contains results on transfusion of blood component therapies- comparing 
ONCAB and OPCAB surgeries.  There was no significant difference in total volume of 
blood products transfused between the two groups.  That is, among those patients 
transfused in ONCAB and in OPCAB, average total volumes of RBCs, FFP, platelets, 
cryoprecipitate, and cell saved blood were similar.  Of interest, the incidence of RBC 
transfusion was also comparable.  In contrast, both rates of FFP (20% vs. 8%; p<0.001) 
and platelets transfusion (35% vs. 10%; p<0.001) were significantly greater in ONCAB 
vs. OPCAB. 
Postoperative Acute Kidney Injury 
Using the KDIGO criteria for AKI, the overall incidence of postoperative AKI 
was comparable between ONCAB vs. OPCAB [33.3% (n=126) and 34.5% (n = 88)].  In 
both groups, the majority of patients experienced stage I AKI  [ONCAB (91%) vs 
OPCAB (83.3%)]; stages II (0% vs. 7%), and stage III (9% vs. 11%). 
Consistent with our prior work, we investigated the influence of platelets on 
postoperative AKI.  Whereas the incidence of severe thrombocytopenia was similar in 
ONCAB vs OPCAB, patients (combined ONCAB and OPCAB) who developed severe 
thrombocytopenia (n=36) had a higher rate of AKI as compared to those with normal 
platelet counts (55.6% vs. 32.4%; p=0.004). Further, intragroup analysis (ONCAB only) 
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demonstrated a significantly higher incidence of AKI in those with severe postoperative 
thrombocytopenia [62% (n=13) vs. 32% (n = 113); p =<0.004] as compared to patients 
with “normal” platelet counts. The same analysis was conducted in OPCAB patient 
showing a non-significant incidence of AKI (47% vs. 34%; p = 0.31) for severe 
thrombocytopenia vs. normal platelet counts. 
Postoperative Bleeding 
Postoperative bleeding was evaluated by total chest tube outputs and by 
mediastinal re-exploration for bleeding.  Overall chest tube outputs were unremarkable 
between ONCAB and OPCAB (832 ± 364 mls vs. 940 ± 537 mls, p=0.05) and no 
difference in re-exploration was observed.
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Discussion 
The hematologic effects of either ONCAB or OPCAB remain poorly studied.  As 
such, based on available and relevant information, we surmised that compared to 
OPCAB, CPB associated hematologic derangements in ONCAB surgery would have a 
more profound effect on postoperative platelet counts, anemia, bleeding, and transfusion 
requirements.   Also, based on our previous work linking thrombocytopenia to 
postoperative AKI in ONCAB surgery, we designed the current study to investigate the 
relation between postoperative platelets and AKI in ONCAB and in OPCAB.   
Our findings are intriguing as both ONCAB and OPCAB surgeries resulted in 
similar and significant postoperative reduction from baseline values for platelets and for 
hemoglobin.  Further, rates of severe thrombocytopenia, volume of chest tube outputs, 
incidence of AKI, and transfusion of RBCs were comparable in ONCAB vs. OPCAB.  
We did observe a near two-fold increase in transfusion rate for FFP and a near three-fold 
higher rate for platelets transfusion in the ONCAB vs. OPCAB procedure.   
 
Perioperative Platelets and Clinical Implications in CABG Surgery 
Platelet activation during cardiac surgery is well recognized, and several studies 
have shown its role in perioperative stroke and myocardial infarction.14 During and after 
CPB, complex pathophysiologic processes in both humoral and cellular processes occur 
that involve coagulation factors, platelets, fibrinogen, vascular endothelium, and 
leukocytes, which may promote a shift in risks from bleeding toward 
microthrombosis.15,16 In certain perioperative conditions, a transition zone between 
bleeding-related and thrombosis-promoting coagulopathy is likely present; while in other 
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settings, bleeding and microthrombosis can occur concurrently, as observed in 
disseminated intravascular coagulation.17 
Nevertheless, CPB has also been shown to promote formation of microemboli 
consisting of fibrin, activated leukocytes, and aggregated platelets. In addition, recent 
evidence supports the role of platelets15,16 in defining endothelial responses and 
neutrophil recruitment in ischemia/reperfusion injury including distant organ injury18 and 
postischemic renal failure.19 It is noteworthy that thrombocytopenia is one of the most 
common laboratory abnormalities in critically ill patients, and has been attributed in this 
setting to increased platelet destruction (immune and non-immune), hemodilution, 
platelet sequestration, or decreased production.20,21 Importantly, such thrombocytopenia 
is closely associated with prolonged ICU length of stay, reduced survival and increased 
incidence of AKI.22,23  
We recently reported a significant association between postoperative nadir 
platelet counts and postoperative AKI.8 The magnitude of decrease in platelet counts 
correlated significantly with the severity of kidney injury, as well as short-term 
mortality.8  While a significant drop in platelet counts is prevalent after CPB, the 
implication of this finding has not been comprehensively examined in a cardiac surgical 
patients undergoing OPCAB surgery.  Our findings are novel as the pattern of reduction 
in platelet counts and its postoperative recovery in ONCAB was very similar OPCAB- 
suggesting that CABG surgery itself- irrespective of CPB- causes profound effects on 
platelet activation and consumption.   These findings were unexpected as conventional 
teaching and thinking would support a greater CPB-associated quantitative and 
qualitative platelet derangement as compared to OPCAB.  Our findings also challenge 
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conventional views on bleeding risks in ONCAP vs. OPCAB.  It is opined that together 
with platelet abnormalities, hemodilution, and marked reduction of coagulation factors 
and fibrinogen would increase bleeding in ONCAB vs. OPCAB.  Based on chest tube 
outputs, we could not demonstrate a difference in bleeding between the two cohorts.  We 
found similar transfusion rate of RBCs- also raising an important question regarding pre-
existing clinical beliefs about hematologic effects of CPB in relation to major vascular 
surgery without use of CPB.  Nevertheless, we acknowledge that effects of CPB on 
platelet counts cannot be overlooked as our study found thrice the rate of platelets 
transfusion in ONCAB vs OPCAB.  Giving the retrospective design of our study; lack of 
a protocol-guided transfusion practice; and qualitative assessment of platelet function, it 
remains uncertain whether transfusion of platelets and FFP were driven by subjective vs. 
objective factors.  
Consistent with our previous report, postoperative thrombocytopenia was 
associated with AKI.  Overall, compared to patients with normal platelet counts, the 
presence of postoperative severe thrombocytopenia significantly increased the rate of 
AKI  (56% vs. 34%).  Importantly, when we analyze severe thrombocytopenia (platelet 
counts <75K) as a predictor of AKI, we also found a significant association in ONCAB 
patients but not in OPCAB (47% vs. 34%, p=0.31). This is likely because of the small 
sample size of patients with severe thrombocytopenia (n= 15) in the OPCAB cohort.  Our 
rationale for exploring AKI in patients in the lowest tertile is because this level of 
thrombocytopenia (platelet counts <75) reflects a clinically important threshold of 
platelet counts.  Further, this approach should be a less arbitrary threshold for defining 
thrombocytopenia (i.e. platelet counts < 100K) as is commonly chosen in some studies.  
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In the OPCAB cohort, the incidence of AKI in thrombocytopenic patients was also much 
higher than in patients with normal platelet counts  
 
Postoperative Anemia and Recovery in ONCAB vs. OPCAB 
We demonstrated that the magnitude of anemia after surgery and its recovery was 
similar in OPCAB as observed in ONCAB.  This finding also differs from our hypothesis 
as we surmised that CPB-associated consumptive processes, hemodilution, and bleeding 
would result in a more profound anemia, greater RBC transfusion and a slower recovery 
of anemia as compared to the OPCAB approach. Thus, these findings raise many 
questions regarding hemostatic effects of CABG surgeries and their management.  Are 
anesthesiologists, cardiac surgeons, and intensivist less restrictive with fluid 
administration in OPCAB vs. ONCAB? Does OPCAB surgery have similar consumptive 
and damaging effects on RBCs as seen in ONCAB? Should there be similar transfusion 
triggers in OPCAB as in ONCAB?   
 
Limitations 
 Because data was not acquired prospectively, there are two instances of potential 
human errors.  First, when clinical information was first documented into medical 
records.  Second, when the information was retrieved from medical records.  Thirdly, all 
of the information was acquired from electronic medical records; therefore, several 
missing data points could not be retrieved.  
 Our study was conducted at a single tertiary medical center. This fact limits the 
applicability of our results to study populations at other centers.  Nevertheless, we had 
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sufficient data on perioperative hematologic factors (platelets, hemoglobin, creatinine, 
chest tube outputs, and specific transfusion therapies)- allowing for relevant and adequate 
comparisons of predictor and outcome variables between ONCAB and OPCAB patients.  
 Lastly, we are not able to provide causes of postoperative anemia and 
thrombocytopenia or a more precise mechanism of platelet associated AKI.   
 
Conclusion  
Our study reveals that ONCAB and OPCAB surgeries are associated with similar 
hematologic effects such as postoperative thrombocytopenia, anemia, transfusion rates of 
RBCs, chest tube outputs, and incidence of AKI.   We also observe higher rates of FFP 
and platelets transfusion in the ONCAB group.  Lastly, patterns of postoperative recovery 
of both platelet counts and anemia were similarly protracted in both ONCAB and 
OPCAB.  Future studies on mechanisms of hematologic derangements in OPCAB 
surgery are warranted. 
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Table 1: Demographics, Medical History, Laboratory Values, and Acute Kidney Injury 
 
 
 
 
 
 
 
 OPCAB (N = 253) ONCAB (N =376) P Values 
Age 67.38 (9.97) 67.29 (9.53) 0.94 
Male 182 (71.94%) 298 (79.26%)  
Female 71 (28.06%) 78 (20.74%)  
Medical History 
COPD 31 (12%) 62 (16.5%) 0.14 
PVD 42 (17%) 40 (11%) 0.029 
CVA 14 (5.5%) 28 (7.5%) 0.35 
Diabetes 103 (40.7%) 153(40.7%) 1.00 
Preoperative laboratory Values 
Creatinine Baseline
b
 
1.15 ± (0.78) 1.15 ± (0.56) 0.99 
Platelets Baseline 209.00± (80) 218.50± (73) 0.97 
Hemoglobin Baseline 13.60± (1.8) 13.25± (1.9) 0.1505 
Post operative clinical events 
Acute Kidney Injury 088 (34.51%) 126 (33.25%) 0.74 
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Table 2.  Perioperative Platelet Counts in ONCAB vs. OPCAB 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OPCAB  ONCAB  
 
Median  min max median min max P value 
Baseline 209 121 609 219 120 790 0.05 
Nadir  139 83 380 132 81 357 0.14 
Discharge 233 92 662 215 104 616 0.055 
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Table 3.  Perioperative Hemoglobin Values in ONCAB vs. OPCAB 
 OPCAB  ONCAB  
 
median min max  median min max P value 
Baseline 13.6 7.9 17.5 13.3 7.2 18.2 0.15 
Nadir 9.40 7.9 14.6 9.50 7.2 17.2 0.95 
Discharge 10.60 7.9 15.4 10.30 7.2 19.3 .002 
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Table 4: Transfusion Patterns in ONCAB and OPCAB Surgeries 
 OPCAB (n=255) ONCAB (n = 379) P-value 
Red Blood Cells  079 (31%) 129 (34%) 0.45 
Fresh frozen plasma  020 (8%) 0069 (18.6%) <0.001 
Platelets  025 (10%) 131 (35%) <0.001 
Cryoprecipitateá  005 (2%) 008 (2%) 0.91 
Cell Saver  0204 (81%) 318 (85%) 0.22 
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Figure 1a:  1b 
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Perioperative platelet counts profile and recovery.  1a (left) depict % change in 
platelet counts and figure 1b representing absolute changes in platelets from 
baseline.  Note, similar trajectories in decline and postoperative recovery of platelet 
counts were observed in both groups.  Further, nadir platelet counts was noted on 
postoperative day 2 in ONCAB and in OPCAB surgeries. 
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Perioperative hemoglobin values and recovery.  1a (left) depicts % change in hemoglobin and 
figure 1b representing absolute changes in hemoglobin from baseline.  Note, similar 
trajectories in both decline in hemoglobin and postoperative recovery of anemia were observed 
in both groups.  Further, nadir hemoglobin values were noted on postoperative day 2 for 
OPCAB and on POD4 for ONCAB surgery.  Importantly, recovery from anemia was 
protracted and markedly incomplete at time of discharge. 
 
 
 
 
 
 
